SEC Form 4 · accession 0000921895-18-002601
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Viraj J Patel
Officer — Chief Financial Officer
Period of report
Sep 12, 2018
Accepted (ET)
Sep 14, 2018 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F1 | $1.45 | Sep 12, 2018 | A | 200,000 | A | — | — | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The options vest on the first anniversary of the grant date. The options will expire on the sixth anniversary of the grant date.